Xamarult Trademark Details

Xamarult was registered on Tuesday, June 22, 2010 and is currently owned by Sanofi under the registration number 3805819 . This mark is alive with a status of Registered. The last case file activity for this mark occured 13 years ago on Tuesday, June 22, 2010, according to the United State Patent & Trademark Office
Word Mark Xamarult
Status Alive Registered 700 — Registered

Current Owner

Sanofi of Paris, TX

View all trademarks for Sanofi
Other Trademarks for Sanofi

Previous Owners

Sanofi-Aventis of Paris, TX

View all trademarks for Sanofi-Aventis
Other Trademarks for Sanofi-Aventis
Serial Number 77777389
Registration Number 3805819
Status Date Tuesday, June 22, 2010
Filing Date Tuesday, June 22, 2010
Registration Date Tuesday, June 22, 2010
Attorney Susan Upton Douglass
Domestic Representative Susan Upton Douglass

Correspondent

SUSAN UPTON DOUGLASS
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
866 UNITED NATIONS PLZ
NEW YORK, NY 10017-1822

Case File Statements

Goods & Services Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases, infectious diseases, and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases
Translation of Words in Mark The wording "XAMARULT" has no meaning in a foreign language.

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Monday, July 13, 2009
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.